Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Active Pharmaceutical Ingredients. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101307040B details a novel NBS addition method for separating Paclitaxel from Cephalomannine, offering significant cost reduction in API manufacturing and high purity.
Patent CN1972898A details a novel Rh-catalyzed asymmetric hydrogenation process for unprotected beta-amino acids, offering significant cost reduction and streamlined API manufacturing.
Patent CN114075258A reveals a hypochlorite-based purification and resin hydrolysis route for hydrocortisone, offering >99.5% purity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN116761809A discloses Fmoc solid-phase synthesis for ACTH. Achieves 99% purity and 63% yield. Ideal for reliable API intermediate supplier partnerships.
Patent CN109748950B reveals a novel Pd-catalyzed solid-phase method for Selepressin, offering high purity and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN103936813A reveals a green synthetic method for Desonide with higher yield and purity, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
This report analyzes patent CN114380729B for vildagliptin production offering high purity and yield advantages for pharmaceutical supply chains and procurement teams globally.
Patent CN114736144B reveals high-purity docusate calcium synthesis. Offers superior powder form, cost reduction in pharmaceutical manufacturing, and reliable supply chain solutions.
Novel DAC chromatography method ensures ICH compliant Orlistat purity with reduced solvent waste and enhanced supply chain reliability for global pharmaceutical manufacturing.
Patent CN102731506B reveals water-based hydrogenation deprotection improving purity and reducing heavy metals for scalable carbapenem antibiotic manufacturing supply chains.
Patent CN107129516A reveals a copper-catalyzed oxidation method for high-purity progesterone. This process offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105732798B details a liquid-phase fragment condensation method for Liraglutide, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113993851A details a novel Valsartan refining method reducing NDMA to ≤0.03ppm. Discover the cost-effective, scalable acid-base purification technology for high-purity API manufacturing.
Novel patent CN119409709A details high-yield lornoxicam preparation reducing impurities and enhancing supply chain reliability for pharmaceutical manufacturing.
Patent CN101597325B details a scalable RP-HPLC purification method for Leuprorelin, ensuring high purity and yield for pharmaceutical supply chains.
Novel azeotropic dehydration method for Esomeprazole sodium ensures high purity and yield. Optimized for commercial scale-up and supply chain reliability in pharmaceutical manufacturing.
Patent CN113754666A details a safe, high-yield synthesis of benzopyrazine compounds using Ring-Closing Metathesis, offering reliable API intermediate supply chains.
Patent CN105985990B details a green enzymatic route for phenylephrine intermediates using KRED and antioxidants, offering significant cost reduction in API manufacturing.
Novel steroid synthesis route improves yield and reduces cost for desoximetasone manufacturing, offering reliable supply chain solutions.
Advanced one-pot synthesis for Febuxostat intermediates ensuring high purity and reduced genotoxic impurities. A cost-effective solution for pharmaceutical manufacturing.